Get started
INNOCAN PHARMA CORP.INNOCAN PHARMA CORP.INNOCAN PHARMA CORP.

INNOCAN PHARMA CORP.

No trades
See on Supercharts
Overview
Financials News Ideas

IP4 chart

Key stats

Market capitalization
‪49.37 M‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0170EUR
Net income
‪−4.34 M‬EUR
Revenue
‪12.60 M‬EUR
Shares float
‪203.51 M‬
Beta (1Y)
0.02

About INNOCAN PHARMA CORP.

Sector
Health Technology
CEO
Iris Or Gabi Bincovich
Headquarters
Calgary
Website
innocanpharma.com
Employees (FY)
9
Founded
2018
ISIN
CA45783P1027
FIGI
BBG00SXHX1K3
InnoCan Pharma Corp. operates as a pharmaceutical tech company. Its segments include: Pharmaceuticals and Consumer Wellness. The Pharmaceuticals segment focuses on developing innovative drug delivery platform technologies based on advanced cannabinoids science. It involves two drug delivery technologies: LPT CBD- loaded liposome platform and CLX CBD-loaded exosomes platform. The Consumer Wellness segment develops and markets a wide portfolio of innovative and self-care products to promote a healthier lifestyle. The company was founded in October 2017 and is headquartered in Alberta, Canada.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange INNOCAN PHARMA CORP. stocks are traded under the ticker IP4.
Yes, you can track INNOCAN PHARMA CORP. financials in yearly and quarterly reports right on TradingView.
IP4 net income for the last quarter is ‪−822.12 K‬ EUR, while the quarter before that showed ‪−1.89 M‬ EUR of net income which accounts for 56.57% change. Track more INNOCAN PHARMA CORP. financial stats to get the full picture.
No, IP4 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IP4 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INNOCAN PHARMA CORP. stock right from TradingView charts — choose your broker and connect to your account.
IP4 reached its all-time high on Nov 4, 2003 with the price of 16.0000 EUR, and its all-time low was 0.0010 EUR and was reached on Oct 6, 2015.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 9.00 employees. See our rating of the largest employees — is INNOCAN PHARMA CORP. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INNOCAN PHARMA CORP. EBITDA is ‪−3.48 M‬ EUR, and current EBITDA margin is −27.60%. See more stats in INNOCAN PHARMA CORP. financial statements.